IonQ, Inc. — Q2 2022 Form 10-Q
Business context and reporting period. IonQ develops trapped-ion quantum computers and sells access through quantum-computing-as-a-service (QCaaS) and related consulting. This unaudited filing covers the three and six months ended June 30, 2022; comparative results are for 2021.
Financial performance and position
| Metric | Q2 2022 | Q2 2021 | Six months 2022 | Six months 2021 |
|---|---|---|---|---|
| Revenue | $2.6 million | $0.1 million | $4.6 million | $0.2 million |
| Operating loss | $(18.9) million | $(10.0) million | $(37.2) million | $(17.3) million |
| Net loss | $(1.7) million | $(10.0) million | $(5.9) million | $(17.3) million |
| Operating cash used | — | — | $(16.9) million | $(9.8) million |
- Revenue rose 2,704% year over year in Q2 and 1,992% for the first half, primarily from new contracts and increased services through cloud providers. The business remains at an early revenue stage.
- Operating expenses were $21.5 million in Q2 and $41.8 million for the first half. Research and development, general and administrative, and sales and marketing spending all increased, including from higher headcount and stock-based compensation.
- Net loss was substantially lower than operating loss because of non-cash gains from remeasuring warrant liabilities: $16.1 million in Q2 and $29.5 million for the first half. Interest income was $1.3 million and $1.9 million, respectively. These gains are not operating revenue.
- Q2 cost of revenue, excluding depreciation and amortization, was $0.7 million; the resulting gross profit proxy was $1.9 million, or about 72% of revenue. This is not a fully allocated gross margin because depreciation and amortization is reported separately.
- Cash, cash equivalents and available-for-sale investments totaled $571.3 million at June 30, 2022, including $44.0 million cash and $379.4 million short-term investments. Total assets were $617.0 million; stockholders’ equity was $592.7 million; accumulated deficit was $151.7 million.
- No borrowings or conventional debt balance is reported in the supplied balance sheet. Total liabilities were $24.3 million, including $6.7 million of operating lease obligations (of which $0.7 million is due within 12 months). The filing states cash and investments should fund working capital and capital needs for at least 12 months.
- Investing cash outflow of $339.2 million for the first half mainly reflects purchases of available-for-sale securities, offset partly by maturities and sales; it is not equivalent to operating cash burn. Capital expenditures for property and equipment were $7.0 million.
Material changes versus the prior comparable period
- Revenue increased from a very small base, while operating expenses more than doubled in the first half. First-half operating cash use increased to $16.9 million from $9.8 million.
- Cash and cash equivalents fell from $399.0 million at year-end 2021 to $44.0 million, while short- and long-term investments rose to $527.4 million combined. The company shifted substantial funds into securities; total cash, cash equivalents and investments declined to $571.3 million from $602.6 million.
- Available-for-sale investments recorded $6.9 million of unrealized losses in accumulated other comprehensive loss, primarily attributed to interest-rate movements. Management said it did not consider the securities other-than-temporarily impaired and did not expect to be required to sell them before recovery.
- Stock-based compensation expense, net of capitalized amounts, increased to $12.6 million for the first half from $3.9 million. Weighted-average shares for the six-month period increased to 196.7 million from 119.0 million, reflecting the post-business-combination capital structure and subsequent share activity.
Outlook, risks and unusual items
- Management expects significant losses and higher operating expenses for the foreseeable future as it funds research, development, commercialization and growth. The filing says significant production is not expected before 2025 at the earliest, and may occur later or never.
- Management expects $19.3 million of revenue from unsatisfied or partially unsatisfied non-cancelable performance obligations as of June 30: $4.9 million in the remaining six months of 2022, $8.0 million in 2023 and $6.4 million thereafter. These are contracted obligations, not a general revenue forecast.
- Management cited paid Airbus and Dow contracts, work with GE Research, cloud-platform availability and quantum-system development as commercial and technical developments. It reported Aria at #AQ 23 and Harmony at up to #AQ 9; these are company-reported technical benchmarks, not evidence of broad quantum advantage.
- The company says it has not produced a scalable quantum computer. Key risks include technical and manufacturing execution, customer adoption, competition, dependence on cloud providers and specialized suppliers, and the possibility that quantum advantage or commercial production is delayed or never achieved.
- Disclosure controls and procedures were assessed as ineffective due to a continuing material weakness in the financial-statement close process and accounting systems. Remediation steps were underway, but the weakness was not yet considered remediated.
- Two securities class actions filed in May and June 2022 allege federal securities-law violations and seek unspecified damages. The company disputes the allegations and says it cannot reasonably estimate any potential loss. A separate legacy dMY-related litigation matter is also disclosed; management did not expect it to materially affect future financial position, results or cash flows.
- The filing notes a short-seller report published May 3, 2022 and warns of possible regulatory inquiries; it does not state in the supplied text that an investigation had been initiated.
- Other unusual items include the warrant-liability fair-value gains that materially reduced reported net loss, and the investment portfolio’s unrealized losses. The company also disclosed customer and related-party concentration: revenue was primarily from four significant customers in Q2 2022, and related-party revenue from the University of Maryland was $1.0 million in Q2.
Important facts for investors to verify
- How much recurring, usage-based QCaaS revenue is developing, and how concentrated are revenues among major customers and cloud platforms?
- Whether technical milestones, manufacturing plans and the stated production timeline are achieved, and whether reported qubit benchmarks translate into customer demand or commercial advantage.
- Whether operating cash burn and expenses accelerate as management anticipates, and how long the cash-and-investment runway remains under updated spending plans.
- Whether the material weakness is fully remediated and controls operate effectively for a sufficient period.
- Developments in the securities class actions, the legacy litigation and any regulatory inquiries associated with the short-seller report.
- Portfolio liquidity and interest-rate exposure, as well as potential dilution from outstanding options, RSUs and warrants.